|TELIK INC. Patent applications|
|Patent application number||Title||Published|
|20130217653||FORMULATIONS OF CANFOSFAMIDE AND THEIR PREPARATION - This invention provides stable, lyophilized formulations of canfosfamide as well as the methods of preparation of those stable lyophilized formulations.||08-22-2013|
|20130184280||SUBSTITUTED THIAZOLES AS VEGFR2 KINASE INHIBITORS - Disclosed herein are substituted thiazoles and their salts that are VEGFR2 kinase inhibitors, useful in the treatment of cancer.||07-18-2013|
|20130035389||METHODS FOR TREATING MYELODYSPLASTIC SYNDROME WITH EZATIOSTAT - This invention relates to methods, assays, devices and systems for identifying patients having a myelodysplastic syndrome for treatment with ezatiostat or a salt thereof, or evaluating the patient's response possibility to the treatment by measuring and evaluating the patient's gene expression profile. This invention also relates to methods of treating myelodysplastic syndromes.||02-07-2013|
|20120165260||CRYSTALLINE EZATIOSTAT HYDROCHLORIDE ANSOLVATE - Crystalline ezatiostat hydrochloride ansolvate form D is more stable and/or more soluble that various solvated crystalline polymorphic forms of ezatiostat hydrochloride.||06-28-2012|
|20120101286||SUBSTITUTED 4-AMINO-5-BENZOYL-2-(PHENYLAMINO)THIOPHENE-3-CARBONITRILES AND SUBSTITUTED 4-AMINO-5-BENZOYL-2-(PHENYLAMINO)THIOPHENE-3-CARBOXAMIDES AS TUBULIN POLYMERIZATION INHIBITORS - Substituted 4-amino-5-benzoyl-2-(phenylamino)thiophene-3-carbonitriles and substituted 4-amino-5-benzoyl-2-(phenylamino)thiophene-3-carboxamides and their salts are tubulin polymerization inhibitors, useful in the treatment of cancer.||04-26-2012|
Patent applications by TELIK INC.